This was strong evidence that FGF9 is a driver of the aggressive phenotype of hepatoma/hepatocarcinoma cells, mediated via FGFR3‐IIIb and/or FGFR3‐IIIc. Here, FGF9 is linked to hepatocellular carcinoma.